Abstract
The new 6th edition of this respected management report is the essential
reference work for everyone in the field. The report covers 121 companies -
from the largest blue-chip multinational to smaller specialist organisations -
and all phases of development from research to launched products.
Detailed analysis of the structure, performance and research of leading cancer drug development companies.
By 2012, the global cancer market is expected to generate revenues in excess
of US$65 billion due to growth in the sales of existing products and the
launch of nearly 60 new products, which will account for around 30% of total
drug launches. These will offset the decline in sales of cytotoxics and
antihormonals, which face generic competition and the uptake of newer products
in preference to these older agents.
The cancer treatment market is set to change radically as newer targeted
therapies replace broader spectrum treatments. They are generally better
tolerated, less toxic and provide better patient outcomes. A trend also to be
noted is the rise of combination therapies and earlier drug intervention,
often at the surgical stage. Against these positive trends is a growing
concern about the rising cost of cancer drugs. With several products now
costing US$10,000+, the balance of meeting medical demands against the cost of
treatment is an issue in all developed countries.
In the challenging cancer therapeutic market, which companies have the products, research and thinking that will shape the future market?
The new updated and expanded 6th edition of this highly respected management
report, Who' s Developing What in New Cancer Drugs 2007? is the
essential reference work for everyone in the field. The report covers 121
companies - from the largest blue-chip multinational to smaller specialist
organisations - and all phases of development from research to launched
products.
Competition for market voice, valuable licensing deals and funding is fierce in a sector characterised by novel research and the promise of significant clinical benefits and commercial return.
Cancer continues to dominate industry research and investment as the search
for really effective therapies hots up. The commercial rewards for companies
that make significant breakthroughs in the cure or control of key cancers such
as breast, ovarian, lung and prostate are considerable.
The application of biotechnology to the identification and development of drug
candidates has seen a variety of novel paths pursued by a range of development
companies.
For analysts, investors and pharmaceutical company executives, being able to
readily and easily assess these companies, the research they are pursuing,
products being developed, collaborators and financial performance/funding is
key to understanding this sector of the pharmaceutical market.
Table of Contents
Volume 1: A - F
ACCESS PHARMACEUTICALS INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
ACTIVE BIOTECH AB
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ADVENTRX PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
AETERNA ZENTARIS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ALCHEMIA LIMITED
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ALFACELL CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ALLOS THERAPEUTICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- DISCONTINUED PROJECT
- FINANCIALS
AMBRILIA BIOPHARMA INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
AMGEN INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
ANGIOGENE PHARMACEUTICALS LTD
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
ANTICANCER INCORPORATED
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
ANTIGENICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ANTISENSE PHARMA GMBH
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ANTISOMA PLC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ARIAD PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ARIUS RESEARCH INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ARK THERAPEUTICS GROUP PLC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ARQULE INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ARRAY BIOPHARMA INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ASTRAZENECA PLC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
ATTENUON LLC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
AVAX TECHNOLOGIES INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
BAYER AG
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- DEPRIORITISED PROJECTS
- DISCONTINUED PROJECT
- FINANCIALS
BIOGEN IDEC INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
BIOMIRA INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
BIONUMERIK PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
BIOVEX INC
- R&D PIPELINE TABLE
- OVERVIEW
- R&D PROJECTS
- FINANCIALS
BRISTOL-MYERS SQUIBB COMPANY
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
BTG INTERNATIONAL LIMITED
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
CALLISTO PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CAN-FITE BIOPHARMA LTD
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CEL-SCI CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CELGENE CORPORATION
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
CELL GENESYS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CELL THERAPEUTICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CEPHALON INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
CLAVIS PHARMA A/S
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
COLEY PHARMACEUTICAL GROUP
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CURAGEN CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
CYCLACEL LIMITED
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- PRODUCT PORTFOLIO
- FINANCIALS
CYTOKINETICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
DAIICHI SANKYO COMPANY LIMITED
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
DENDREON CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ELI LILLY AND COMPANY
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
ENDOCYTE INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ENTREMED INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ENZON PHARMACEUTICALS INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
EPICEPT CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
EXELIXIS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
FAVRILLE INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
Volume 2: G - M
GAMIDA CELL LTD
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
GENENTECH INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
GENITOPE CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
GENMAB A/S
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- DISCONTINUED AGREEMENT
- R&D PROJECTS
- FINANCIALS
GENTA INCORPORATED
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
GENVEC INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
GENZYME ONCOLOGY
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
GERON CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
GLAXOSMITHKLINE PLC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
GPC BIOTECH AG
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
HANA BIOSCIENCES INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
HUMAN GENOME SCIENCES INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
IDERA PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
IDM PHARMA INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
IMCLONE SYSTEMS INCORPORATED
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
IMMUNOGEN INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
IMMUNOMEDICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
INTROGEN THERAPEUTICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ISIS PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
KERYX BIOPHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
KIRIN HOLDINGS COMPANY LIMITED
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
KOSAN BIOSCIENCES INCORPORATED
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- DISCONTINUED AGREEMENT
- R&D PROJECTS
- FINANCIALS
KYOWA HAKKO KOGYO CO LTD
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
LIGAND PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
LORUS THERAPEUTICS INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
MARSHALL EDWARDS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
MEDAREX INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
MEDIGENE AG
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
MERCK KGAA
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
METHYLGENE INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
MGI PHARMA INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
MICROMET INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
MILLENNIUM PHARMACEUTICALS INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
Volume 3: N - Y
NEOPHARM INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
NORTHWEST BIOTHERAPEUTICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
NOVACEA INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
NOVARTIS INTERNATIONAL AG
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
ONCOGENEX TECHNOLOGIES INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ONCOLYTICS BIOTECH INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ONYVAX LIMITED
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
ONYX PHARMACEUTICALS INC
- AGREEMENTS TABLE
- PRODUCT TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
OSI PHARMACEUTICALS INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
OXFORD BIOMEDICA PLC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
OXIGENE INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
PANACEA PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
PEREGRINE PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
PFIZER INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
PHARMACYCLICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
PHARMAMAR SA
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
PHOTOCURE ASA
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
PROGEN PHARMACEUTICALS LIMITED
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
PROGENICS PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
PROTHERICS PLC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
QUEST PHARMATECH INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
F HOFFMANN-LA ROCHE LTD
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- DISCONTINUED AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
SANOFI-AVENTIS GROUP
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
SCHERING-PLOUGH CORPORATION
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
SEATTLE GENETICS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
SPECTRUM PHARMACEUTICALS INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
SUPERGEN INC
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
SYNTA PHARMACEUTICALS CORP
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
TEKMIRA PHARMACEUTICALS CORPORATION
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
TELIK INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
TOPOTARGET A/S
- AGREEMENTS TABLE
- PRODUCT PORTFOLIO TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- PRODUCT PORTFOLIO
- R&D PROJECTS
- FINANCIALS
TRANSGENE SA
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
VICAL INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
VION PHARMACEUTICALS INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
VIREXX MEDICAL CORP
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
VIVENTIA BIOTECH INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
WILEX AG
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
YM BIOSCIENCES INC
- AGREEMENTS TABLE
- R&D PIPELINE TABLE
- OVERVIEW
- AGREEMENTS
- R&D PROJECTS
- FINANCIALS
医薬品
その他のカテゴリ
FAQ